Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-05-08
Original SEC Filing: Click here

---

Webplus: SVA/20180508/6-K/2_EX-99.1/000.htm SEC Original: tv493375_ex99-1.htm
Sinovac Forced to Temporarily Suspend Hepatitis A Vaccine Production Line Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing Actions of Aihua Pan continue to harm the Company’s shareholders and customers BEIJING, May 8, 2018 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac ” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it

---

---

Webplus: SVA/20180508/6-K/1/000.htm SEC Original: tv493375_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-05-08CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200